AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gblin 150mg Tablet

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Pregabalin (150mg)

Overview Gblin 150mg Tablet

Neuropain 150mg tablets alleviate nerve pain stemming from diabetes, shingles, spinal cord injury, or similar ailments. This medication also addresses fibromyalgia's characteristic muscle pain and stiffness. Classified as an anticonvulsant, Neuropain 150mg can manage certain seizure types when used with other therapies. It may also treat anxiety symptoms when alternative treatments prove ineffective. Administer Neuropain 150mg with or without food, maintaining consistent daily timing for optimal results. Dosage and treatment length depend on individual response and condition, typically starting with a low dose and gradually increasing. Full therapeutic effect may take several weeks. Adhere strictly to your physician's instructions, ensuring regular intake until cessation is advised; missed doses may exacerbate symptoms. Side effects, often mild and transient, include drowsiness, dizziness, dry mouth, blurred vision, weight gain, generalized edema, and concentration difficulties. While most require no medical intervention, discuss any concerns with your doctor. Inform your physician of pregnancy, breastfeeding, or pregnancy plans prior to use. Exercise caution when driving due to potential drowsiness, dizziness, and visual impairment; alcohol consumption should be avoided to prevent excessive sedation.

Uses of Gblin 150mg Tablet

Managing neuropathic pain, fibromyalgia, and epilepsy/seizures.

Major Benefits of Gblin 150mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gblin 150mg tablets can be consumed with or without food; however, consistent timing is recommended for optimal results.

Common Side effects of Gblin 150mg Tablet:

  • Sleepiness
  • Weight gain
  • Dryness in mouth
  • Blurred vision
  • Dizziness
  • Peripheral edema

How to use Gblin 150mg Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Gblin 150mg Tablet can be consumed with or without food, however, consistent timing is recommended.

How Gblin 150mg Tablet works:

Epileptic seizures are mitigated by the anticonvulsant action of Gblin 150mg Tablets, which are thought to suppress excessive brain electrical discharges. This medication also provides analgesia for neuropathic pain by interrupting the transmission of pain signals along damaged nerves to the central nervous system.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Gblin 150mg tablets and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gblin 150mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gblin 150mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking a 150mg Gblin tablet might cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gblin 150mg Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

Gblin 150mg tablets may be administered to patients with hepatic impairment without modification of the prescribed dosage.

What if you forget to take Gblin 150mg Tablet :

Should you forget a Gblin 150mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gblin 150mg Tablet

LabelValue
Type of Compound GABA-like ring structures
Potential for Dependence None.
Medication Classification Nervous system medications.

FAQs on Gblin 150mg Tablet

Gabapentin 150mg tablets are classified as anticonvulsants. Their primary use is in managing seizures. They are also effective for neuropathic pain stemming from conditions such as diabetes, herpes zoster (shingles), or trauma. Furthermore, gabapentin is employed in the management of fibromyalgia, a chronic disorder characterized by pain, fatigue, muscle stiffness and soreness, and sleep disturbances. In certain instances, physicians may prescribe this medication to alleviate anxiety.
Gblin 150mg Tablets exert varied mechanisms of action depending on the condition being treated. For epilepsy, it mitigates seizures by suppressing excessive brain electrical activity. In chronic pain management, it inhibits the transmission of pain signals between the brain and spinal cord.
Complete therapeutic effects from Gblin 150mg Tablet may become apparent within several weeks. Some individuals, however, report pain reduction after just one week of treatment with Gblin 150mg Tablet.
The prescribed length of Gblin 150mg Tablet treatment varies depending on the underlying medical condition. For epilepsy, continued use for an extended period, potentially years, may be necessary if the medication proves effective. In cases of neuropathic or fibromyalgia pain, treatment might continue for several months after symptom improvement to prevent recurrence. Discontinuing Gblin 150mg Tablets should only occur under the guidance of a physician.
Continue taking your Gblin 150mg Tablet as prescribed, even if you feel well. Abrupt cessation of this medication, particularly if used for epilepsy, risks inducing uncontrollable seizures. Sudden discontinuation can also trigger withdrawal effects such as anxiety, insomnia, nausea, pain, and diaphoresis. These adverse reactions can be mitigated by a phased reduction in dosage.
Misuse of Gblin 150mg Tablets significantly increases the risk of dependence. Exceeding prescribed dosages or prolonged use of Gblin 150mg Tablets can also lead to addiction. Individuals with a history of substance abuse should avoid this medication. Report any signs of physical dependence on Gblin 150mg Tablets to your physician without delay.
Concurrent use of Gblin 150mg tablets and diazepam is possible. However, the combined effect on the central nervous system may heighten the likelihood of adverse reactions due to their shared mechanism of action.
Gblin 150mg tablets are classified as anticonvulsants and are indicated for seizure management. This medication also offers relief from nerve pain (neuropathic pain), potentially stemming from diabetes, herpes zoster (shingles), or trauma. Furthermore, it's employed in the treatment of fibromyalgia, a chronic condition characterized by pain, fatigue, muscle stiffness and soreness, and sleep disturbances. In certain instances, physicians may prescribe Gblin 150mg tablets to manage anxiety.
Gblin 150mg tablets exert varied mechanisms of action depending on the condition being treated. For epilepsy, it suppresses seizures through the modulation of aberrant brain electrical activity. In chronic pain management, it interrupts the transmission of pain signals between the brain and spinal cord.
Complete symptom relief from Gblin 150mg Tablet may require several weeks of treatment. Nevertheless, some individuals report pain reduction within a week of commencing therapy with Gblin 150mg Tablet.
The prescribed length of Gblin 150mg Tablet treatment varies according to the underlying medical issue. Epilepsy management may necessitate long-term, even years-long, use if the medication proves effective. For neuropathic or fibromyalgia pain, continued use for several months after symptom improvement is often recommended to prevent recurrence. Discontinuing Gblin 150mg Tablet should only occur under a physician's guidance.
Continuing your Gblin 150mg Tablet regimen is crucial, even if symptoms improve. Abrupt cessation, especially in epilepsy treatment, risks triggering unrelenting seizures. Sudden discontinuation may also induce withdrawal, potentially causing anxiety, insomnia, nausea, pain, and diaphoresis. A phased reduction in Gblin 150mg Tablet dosage mitigates these withdrawal effects.
Misuse of Gblin 150mg Tablets significantly increases the risk of dependence. Exceeding prescribed dosages or prolonged use of Gblin 150mg Tablets can also lead to addiction. Individuals with a history of substance abuse should avoid this medication entirely. Report any signs of physical dependence on Gblin 150mg Tablets to your physician without delay.
Concurrent use of Gblin 150mg tablets and Diazepam is possible. However, the combined effect on the central nervous system may heighten the risk of adverse reactions due to their shared mechanism of action.
Gblin 150mg Tablets can lead to weight increase due to heightened appetite. Maintaining a stable weight may be aided by regular physical activity and a balanced, low-calorie diet. For additional weight management guidance, seek advice from a registered dietitian.
Gblin 150mg Tablet
86
MRP 105
18% off